Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

744

Participants

Timeline

Start Date

November 29, 2017

Primary Completion Date

September 19, 2022

Study Completion Date

October 12, 2022

Conditions
Breast CarcinomaHead and Neck CancerMelanoma (Skin)Squamous Cell Carcinoma, SkinCervix CancerEndometrium CancerOvary CancerVulva CancerAnus CancerRectum Cancer
Interventions
DRUG

Indocyanine green

Each patient receive injection of indocyanine green just before surgery Specify total dose : 2.5 mg/ml (Intravenous use)

DRUG

Technetium99

"Each patient receives injection of Technetium 99 ( injected in subcutaneously) before surgery.~Lymphoscintigraphy is performed to identify the sentinel node"

DEVICE

Optonuclear probe

The detection of sentinel lymph node will be conducted by an optonuclear probe able to detect the radioactive and the fluorescence signal during surgery.

DEVICE

Quest Camera

The detection of sentinel lymph node will be conducted by a camera able to determine imagery of fluorescence during surgery.

Trial Locations (1)

54519

Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Institut de Cancérologie de Lorraine

OTHER

NCT02997553 - Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery | Biotech Hunter | Biotech Hunter